The Newsroom of Immunophotonics, Inc.

Public Relations
Immunophotonics, Inc.
+1 314-501-1919

Immunophotonics, Inc.
4340 Duncan Avenue, Suite 212
Saint Louis, Missouri, 63110
United States
+1 314-501-1919
Visit Website

Immunophotonics is a privately owned clinical-stage biotech company that is pioneering the burgeoning field of Interventional Immuno-Oncology® through the development of novel treatments for solid-tumor cancers. IP-001, the first asset from the company’s intellectual property platform, has the potential to transform a routine tumor ablation into a systemically active cancer immunotherapy. Immunophotonics is also exploring the use of its technology platform to help prevent and combat contractions of infectious diseases. Immunophotonics is headquartered in St. Louis, Missouri, with a subsidiary in Bern, Switzerland.